Twice daily

WIRE

THU 22 OCTMorning1:07 PM

Back to the brief

HLTHThe Guardian

CDC denies approval for high-volume measles test, citing ‘other priorities’

Photo: Ronaldo Schemidt/AFP/Getty Images

California, Oregon, Washington and Hawaii health officials ask CDC, ‘prioritizing emerging technologies’, to reconsider California and Washington asked the US Centers for Disease Control and Prevention (CDC) in May to validate a new way to test for measles – but after waiting two months, the CDC denied the request, citing “other competing priorities”, according to a letter from the West Coast Health Alliance to the CDC director, Erica Schwartz. The letter, signed by health officials in California , Hawaii, Oregon and Washington, asks Schwartz to…

Read the original report

Opens The Guardian in a new tab

HLTHThe Guardian

Controversial US-backed vaccine trial in African newborns halted

Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.”

Back to the brief